Global Cytokine Profiles and Association With Clinical Characteristics in Patients With Irritable Bowel Syndrome

Overview

Journal Am J Gastroenterol

Specialty Gastroenterology

Date 2016 Jun 9

PMID 27272011

Citations 49

Authors

Sean M P Bennet

Annikka Polster

Hans Tornblom

Stefan Isaksson

Sandrine Capronnier

Aurore Tessier

Boris Le Neve

Magnus Simren

Lena Ohman

Affiliations

Soon will be listed here.

Abstract

Objectives: Evidence suggests that patients with irritable bowel syndrome (IBS) have an altered cytokine profile, although it is unclear whether cytokines are linked with symptom severity. We aimed to determine whether global serum and mucosal cytokine profiles differ between IBS patients and healthy subjects and whether cytokines are associated with IBS symptoms.

Methods: Serum from 144 IBS patients and 42 healthy subjects was analyzed for cytokine levels of interleukin (IL)-5, IL-6, IL-8, IL-10, IL-12p70, IL-13, IL-17A, interferon (IFN)-γ, and tumor necrosis factor (TNF) by MSD MULTI-ARRAY. In total, 109 IBS and 36 healthy sigmoid colon biopsies were analyzed for mRNA expression of IL-8, IL-10, TNF, and FOXP3 by quantitative reverse transcription PCR. Multivariate discrimination analysis evaluated global cytokine profiles. Rectal sensitivity, oroanal transit time, and psychological and gastrointestinal symptom severity were also assessed.

Results: Global cytokine profiles of IBS patients and healthy subjects overlapped, but cytokine levels varied more in IBS patients. Serum levels of IL-6 and IL-8 tended to be increased and levels of IFN-γ tended to be decreased in IBS patients. Mucosal mRNA expression of IL-10 and FOXP3 tended to be decreased in IBS patients. Within both the full study cohort and IBS patients alone, serum level of TNF was associated with looser stool pattern, while subjects with more widespread somatic symptoms had increased serum levels of IL-6. Although neither IBS bowel habit subgroups nor patients with possible post-infectious IBS were associated with distinct cytokine profiles, a small cluster of IBS patients with comparatively elevated immune markers was identified.

Conclusions: Global cytokine profiles did not discriminate IBS patients from healthy subjects, but cytokine profiles were more varied among IBS patients than among healthy subjects, and a small subgroup of patients with enhanced immune activity was identified. Also, association of inflammatory cytokines with some clinical symptoms suggests that immune activation may be of importance in a subset of IBS patients.

Citing Articles

Patients with Irritable Bowel Syndrome Exhibit Aberrant Expression of Endogenous Retroviruses and SETDB1.

Tovo P, Ribaldone D, Caviglia G, Calvi C, Montanari P, Tizzani M Cells. 2025; 14(3).

PMID: 39936987 PMC: 11817187. DOI: 10.3390/cells14030196.

Efficacy and Safety of a Mixture of Microencapsulated Sodium Butyrate, Probiotics, and Short Chain Fructooligosaccharides in Patients with Irritable Bowel Syndrome-A Randomized, Double-Blind, Placebo-Controlled Study.

Gasiorowska A, Romanowski M, Walecka-Kapica E, Kaczka A, Chojnacki C, Padysz M J Clin Med. 2025; 14(1.

PMID: 39797089 PMC: 11720862. DOI: 10.3390/jcm14010006.

Mast cell modulation: A novel therapeutic strategy for abdominal pain in irritable bowel syndrome.

Van Remoortel S, Hussein H, Boeckxstaens G Cell Rep Med. 2024; 5(10):101780.

PMID: 39378882 PMC: 11513802. DOI: 10.1016/j.xcrm.2024.101780.

Tongxieyaofang Decotion Alleviates IBS by Modulating CHRM3 and Gut Barrier.

Feng T, Zhou Y, Lv B, Cai L Drug Des Devel Ther. 2024; 18:3191-3208.

PMID: 39081703 PMC: 11288639. DOI: 10.2147/DDDT.S455497.

Putting Functional Gastrointestinal Disorders within the Spectrum of Inflammatory Disorders Can Improve Classification and Diagnostics of These Disorders.

Sojat D, Volaric M, Keskic T, Volaric N, Cerovecki V, Majnaric L Biomedicines. 2024; 12(3).

PMID: 38540315 PMC: 10967747. DOI: 10.3390/biomedicines12030702.

References

Schmulson M, Pulido-London D, Rodriguez O, Morales-Rochlin N, Martinez-Garcia R, Gutierrez-Ruiz M . Lower serum IL-10 is an independent predictor of IBS among volunteers in Mexico. Am J Gastroenterol. 2012; 107(5):747-53. DOI: 10.1038/ajg.2011.484. View

Cremon C, Gargano L, Morselli-Labate A, Santini D, Cogliandro R, De Giorgio R . Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms. Am J Gastroenterol. 2009; 104(2):392-400. DOI: 10.1038/ajg.2008.94. View

Collins S, Vallance B, Barbara G, Borgaonkar M . Putative inflammatory and immunological mechanisms in functional bowel disorders. Baillieres Best Pract Res Clin Gastroenterol. 1999; 13(3):429-36. DOI: 10.1053/bega.1999.0037. View

Drossman D, Camilleri M, Mayer E, Whitehead W . AGA technical review on irritable bowel syndrome. Gastroenterology. 2002; 123(6):2108-31. DOI: 10.1053/gast.2002.37095. View

Scully P, McKernan D, Keohane J, Groeger D, Shanahan F, Dinan T . Plasma cytokine profiles in females with irritable bowel syndrome and extra-intestinal co-morbidity. Am J Gastroenterol. 2010; 105(10):2235-43. DOI: 10.1038/ajg.2010.159. View

Ohman L, Isaksson S, Lundgren A, Simren M, Sjovall H . A controlled study of colonic immune activity and beta7+ blood T lymphocytes in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol. 2005; 3(10):980-6. DOI: 10.1016/s1542-3565(05)00410-6. View

Chadwick V, Chen W, Shu D, Paulus B, Bethwaite P, Tie A . Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology. 2002; 122(7):1778-83. DOI: 10.1053/gast.2002.33579. View

Elsenbruch S . Abdominal pain in Irritable Bowel Syndrome: a review of putative psychological, neural and neuro-immune mechanisms. Brain Behav Immun. 2010; 25(3):386-94. DOI: 10.1016/j.bbi.2010.11.010. View

Ohman L, Isaksson S, Lindmark A, Posserud I, Stotzer P, Strid H . T-cell activation in patients with irritable bowel syndrome. Am J Gastroenterol. 2009; 104(5):1205-12. DOI: 10.1038/ajg.2009.116. View

10.

Sakaguchi S . Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol. 2004; 22:531-62. DOI: 10.1146/annurev.immunol.21.120601.141122. View

11.

Francis C, Morris J, Whorwell P . The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther. 1997; 11(2):395-402. DOI: 10.1046/j.1365-2036.1997.142318000.x. View

12.

Buckley M, OHalloran K, Rae M, Dinan T, OMalley D . Modulation of enteric neurons by interleukin-6 and corticotropin-releasing factor contributes to visceral hypersensitivity and altered colonic motility in a rat model of irritable bowel syndrome. J Physiol. 2014; 592(23):5235-50. PMC: 4262336. DOI: 10.1113/jphysiol.2014.279968. View

13.

Tornblom H, Van Oudenhove L, Sadik R, Abrahamsson H, Tack J, Simren M . Colonic transit time and IBS symptoms: what's the link?. Am J Gastroenterol. 2012; 107(5):754-60. DOI: 10.1038/ajg.2012.5. View

14.

Bashashati M, Rezaei N, Shafieyoun A, McKernan D, Chang L, Ohman L . Cytokine imbalance in irritable bowel syndrome: a systematic review and meta-analysis. Neurogastroenterol Motil. 2014; 26(7):1036-48. DOI: 10.1111/nmo.12358. View

15.

Kamezaki Y, Katsuura S, Kuwano Y, Tanahashi T, Rokutan K . Circulating cytokine signatures in healthy medical students exposed to academic examination stress. Psychophysiology. 2012; 49(7):991-7. DOI: 10.1111/j.1469-8986.2012.01371.x. View

16.

Maes M, Song C, Lin A, De Jongh R, Van Gastel A, Kenis G . The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety. Cytokine. 1998; 10(4):313-8. DOI: 10.1006/cyto.1997.0290. View

17.

Liebregts T, Adam B, Bredack C, Roth A, Heinzel S, Lester S . Immune activation in patients with irritable bowel syndrome. Gastroenterology. 2007; 132(3):913-20. DOI: 10.1053/j.gastro.2007.01.046. View

18.

Bashashati M, Rezaei N, Andrews C, Chen C, Ebrahimi Daryani N, Sharkey K . Cytokines and irritable bowel syndrome: where do we stand?. Cytokine. 2011; 57(2):201-9. DOI: 10.1016/j.cyto.2011.11.019. View

19.

Zigmond A, SNAITH R . The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983; 67(6):361-70. DOI: 10.1111/j.1600-0447.1983.tb09716.x. View

20.

Raison C, Capuron L, Miller A . Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2005; 27(1):24-31. PMC: 3392963. DOI: 10.1016/j.it.2005.11.006. View